amfAR 
Welcome,         Profile    Billing    Logout  
  Products    Diseases    Products    Trials    News 


«12...9101112131415161718192021»
  • ||||||||||  Vyrologix (leronlimab) / CytoDyn, Vyera Pharma
    Yes for leronlimab! (Twitter) -  Aug 12, 2020   
  • ||||||||||  Selzentry (maraviroc) / ViiV Healthcare, Vyrologix (leronlimab) / CytoDyn, Vyera Pharma
    Journal:  Cytokine CCL5 and receptor CCR5 axis in glioblastoma multiforme. (Pubmed Central) -  Aug 11, 2020   
    CCL5/CCR5 is suggested to be an excellent new target for glioblastoma therapy. The molecular mechanisms, by which chemoattractant and receptor respond within the complex tissue microenvironment to promote cancer stem cells and tumour heterogeneity, should be considered in forthcoming studies.
  • ||||||||||  Vyrologix (leronlimab) / CytoDyn, Vyera Pharma, amfAR
    Enrollment closed, Trial completion date, Trial primary completion date:  Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19 (clinicaltrials.gov) -  Aug 10, 2020   
    P2,  N=86, Active, not recruiting, 
    The molecular mechanisms, by which chemoattractant and receptor respond within the complex tissue microenvironment to promote cancer stem cells and tumour heterogeneity, should be considered in forthcoming studies. Recruiting --> Active, not recruiting | Trial completion date: Apr 2021 --> Aug 2021 | Trial primary completion date: Dec 2020 --> Jul 2020
  • ||||||||||  Vyrologix (leronlimab) / CytoDyn, Vyera Pharma
    What about Leronlimab? (Twitter) -  Jul 24, 2020   
  • ||||||||||  Vyrologix (leronlimab) / CytoDyn, Vyera Pharma
    LERONLIMAB (Twitter) -  Jul 23, 2020   
  • ||||||||||  Vyrologix (leronlimab) / CytoDyn, Vyera Pharma
    Leronlimab tho (Twitter) -  Jul 21, 2020   
  • ||||||||||  Vyrologix (leronlimab) / CytoDyn, Vyera Pharma
    #Leronlimab @CytoDyn (Twitter) -  Jul 1, 2020